| Merkel Cell Carcinoma studied in …STUDIED_INderived133 of 133show fewer |
|---|
| → studied in | NCT05583708Phase 2 · recruiting Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02471352recruiting Studies of Dermatologic Diseases Biospecimen Acquisition Protocol · condition mapped ALIAS · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07006727Phase 1 · recruiting Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06021626Phase 1 · recruiting A Study of CRD3874-SI in People With Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07576725Phase 2 · not yet recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07080242Phase 1 · recruiting Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05358938early Phase 1 · active not recruiting Exercise to Boost Response to Checkpoint Blockade Immunotherapy · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02479698Phase 2 · recruiting Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04047251Phase 1 · active not recruiting A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05864144Phase 1/Phase 2 · completed A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07472322Phase 1/Phase 2 · not yet recruiting ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1 · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05896839Phase 1/Phase 2 · recruiting Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03304639Phase 2 · completed Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04670445NA · completed Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05269381Phase 1/Phase 2 · recruiting Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07115043Phase 1/Phase 2 · recruiting A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978625Phase 2 · active not recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05859074Phase 1 · recruiting A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06056895Phase 2 · active not recruiting Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03816332Phase 1 · active not recruiting Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05947500Phase 2 · active not recruiting Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05078047Phase 3 · active not recruiting Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05100095Phase 2 · recruiting Hypofractionated Radiation Therapy for Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07302347Phase 1/Phase 2 · recruiting A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21) · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04975152Phase 1 · recruiting Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07215988recruiting Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07387198Phase 2 · recruiting Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04616248Phase 1 · active not recruiting In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03271372Phase 3 · active not recruiting Adjuvant Avelumab in Merkel Cell Cancer · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04705389NA · active not recruiting SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05076760Phase 1 · recruiting MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04916002Phase 2 · terminated A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03935893Phase 2 · active not recruiting Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210935recruiting French National Database of Rare Dermatological Cancers · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03583528active not recruiting DOTATOC PET/CT for Imaging NET Patients · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04902040Phase 1/Phase 2 · terminated Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04349436Phase 1/Phase 2 · active not recruiting Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969860Phase 2 · recruiting At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06753136NA · recruiting Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04291885Phase 2 · active not recruiting Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04869137Phase 2 · active not recruiting Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04792073Phase 2 · active not recruiting Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04234113Phase 1 · terminated Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04261855Phase 1/Phase 2 · active not recruiting Targeted Therapy and Avelumab in Merkel Cell Carcinoma · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06008977NA · active not recruiting Exercise to Boost Response to Checkpoint Blockade Immunotherapy · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03071406Phase 2 · active not recruiting Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06223659Phase 2 · recruiting EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05496036Phase 2 · recruiting Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06151236Phase 2 · recruiting Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07288073Phase 2 · recruiting TIL Therapy in cSCC and MCC · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06939036Phase 1/Phase 2 · terminated Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 ) · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03228667Phase 2 · active not recruiting QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05594290Phase 2 · active not recruiting Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04260802Phase 1/Phase 2 · terminated A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04157985Phase 3 · completed Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05120271Phase 1/Phase 2 · active not recruiting BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04725331Phase 1/Phase 2 · terminated A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03901573Phase 1/Phase 2 · terminated High-Risk Skin Cancers With Atezolizumab Plus NT-I7 · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04272034Phase 1 · terminated Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06940440Phase 1 · recruiting IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC) · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06536257recruiting Personalised Immunotherapy Platform · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03599713Phase 2 · completed A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201) · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04116320Phase 1 · terminated Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242199Phase 1 · completed Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086692Phase 1/Phase 2 · recruiting A Beta-only IL-2 ImmunoTherapY Study · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03783078Phase 3 · completed Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913) · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02196961Phase 2 · completed Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03167164Phase 1/Phase 2 · withdrawn QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03212404Phase 1 · active not recruiting Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02819843Phase 2 · completed A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05797415recruiting Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04160065Phase 1 · completed Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03370861terminated How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00655655Phase 1 · completed Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Cutaneous Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04853602available IFx-Hu2.0 Expanded Access Program · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03853317Phase 2 · terminated QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05013099Phase 2 · unknown Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06448611not yet recruiting Identification and Characterization of Circulating Tumor Cells Before and After Treatment (Surgery and Radiotherapy) in a Cohort of Patients Treated for Resectable Stage I-III Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03629756Phase 1 · completed A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04393753Phase 2 · completed Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1 · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05253144NA · completed Comparing Radical Surgery and Radical Radiotherapy as First Definitive Treatment for Primary MCC · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02465957Phase 2 · terminated QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC) · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03798639Phase 1 · completed Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02155647Phase 2 · completed Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200) · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04187872Phase 1 · terminated LITT and Pembrolizumab in Recurrent Brain Metastasis · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05422781Phase 1 · completed Study To Evaluate The Safety, Tolerability And Immunogenicity Of 4 mg Of ITI-3000 In Patients With Polyomavirus-Positive Merkel Cell Carcinoma (MCC) · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06086288Phase 2 · not yet recruiting Study of PembrolizumAb combiNeD With Cisplatin or carbOplatin and Etoposide in Treatment naïve Advanced meRkel Cell cArcinoma (MCC) · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05329792Phase 2 · unknown L19IL2/L19TNF in Skin Cancer Patients · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106167terminated Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06039033not yet recruiting Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02267603Phase 2 · completed Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01440816Phase 2 · completed IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cancer · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02036476Phase 2 · terminated Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03841110Phase 1 · completed FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04590781Phase 1/Phase 2 · terminated Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02890368Phase 1 · terminated Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03435640Phase 1/Phase 2 · terminated REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05429866Phase 2 · unknown Immunological Variables Associated to ICI Toxicity in Cancer Patients · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03787602Phase 1/Phase 2 · unknown Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03545334NA · completed Lymph Node Identification in Skin Malignancy Using ICG Transcutaneously Study · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02643303Phase 1/Phase 2 · completed A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01013779Phase 2 · completed Merkel Positron Emission Tomography (PET) Protocol · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00540566completed Optical Biopsy of Human Skin in Conjunction With Laser Treatment · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04596033Phase 1 · terminated TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02584829Phase 1/Phase 2 · terminated Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03458117Phase 1 · completed T-VEC in Non-melanoma Skin Cancer · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04874831Phase 2 · withdrawn Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma (MERKLIN 1) · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03652077Phase 1 · completed A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03988647Phase 2 · terminated Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02514824Phase 1/Phase 2 · completed MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03538028Phase 1 · completed A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01913691Phase 2 · withdrawn Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03089658approved for marketing Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC) · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02035657Phase 1 · completed A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02054884Phase 2 · terminated F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02351128Phase 2 · completed Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02831179Phase 1 · withdrawn Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01758458Phase 1/Phase 2 · terminated Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01204476Phase 1 · completed Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01155258Phase 1 · completed Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Cutaneous Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01526486NA · completed Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00346385Phase 1 · completed BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002947Phase 1 · terminated Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer · condition mapped ALIAS · 133 trials mapped (59 active) | — | — | Cutaneous Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003514Phase 2 · withdrawn Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004922Phase 2 · completed Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors · condition mapped ALIAS · 133 trials mapped (59 active) | — | — | Cutaneous Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079131Phase 2 · completed Oblimersen in Treating Patients With Merkel Cell Carcinoma · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Cutaneous Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068783Phase 2 · completed S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer · condition mapped CURATED_BROADER · 133 trials mapped (59 active) | — | — | Cutaneous Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003549Phase 2 · completed S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer · condition mapped ALIAS · 133 trials mapped (59 active) | — | — | Cutaneous Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00765193NA · completed The Impact of Total Body Skin Examination on Skin Cancer Detection · condition mapped ONTOLOGY_EXACT · 133 trials mapped (59 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |